Selective binding of elliptinium acetate onto the 3′-terminal ribose of diribonucleosides monophosphates

This publication has 8 references indexed in Scilit:

• Reinvestigation of the reaction of n-2-methyl-9-hydroxyellipticinium acetate with adenosine and methanol.
  Tetrahedron Letters, 1984
• Covalent binding of the antitumor agent N2-methyl-9-hydroxy-ellipticinium acetate (NSC 264137) on RNA and poly a invitro
  Biochemical and Biophysical Research Communications, 1984
• Regioselective arylation of ribose in adenosine and guanosine with the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.
  Proceedings of the National Academy of Sciences, 1984
• Phase II study of 9-hydroxy-2N-methylellipticinium acetate
  European Journal of Cancer and Clinical Oncology, 1984
• Human and rat urinary metabolites of the antitumor drug celiptium ® (N2-methyl-9-hydroxyellipticinium acetate, NSC 264137). Identification of cysteine conjugates supporting the “biooxidative alkylation” hypothesis
  Biochemical Pharmacology, 1983
• o-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate
  Journal of Medicinal Chemistry, 1983
• Unexpected regiospecific alkylation of the antitumor agent N2-methyl-9-hydroxyellipticinium acetate with N, O or S donors
  Tetrahedron Letters, 1983
• HYDROXY-9-METHYL-2-ELLIPTICINIUM FOR OSSEOUS METASTASES FROM BREAST-CANCER - A 5-YEAR EXPERIENCE
  1982